The Liberia Medicines and Health Products Regulatory Authority (LMHRA), in collaboration with key stakeholders, has concluded a two-day high-level conference on Pharmacovigilance and Clinical Trials in Monrovia, bringing together health products regulators from across Africa.
The gathering focused on strengthening regulatory frameworks, improving monitoring systems for medicines and health products, and enhancing collaboration among African nations to ensure the safety and effectiveness of medical products. Speaking at the end of the conference, LMHRA Managing Director Luke L. Bawo emphasized the importance of pharmacovigilance in protecting public health and building trust in clinical trials across the continent.
According to him, the meeting served as a platform to share best practices and align strategies with international standards.
Also, stakeholders, including representatives from regional regulatory bodies, health ministries, and development partners, reaffirmed their commitment to advancing Africa’s capacity to regulate medicines and oversee clinical trials. Director Bawo narrated that the outcome of the conference is expected to shape future regulatory cooperation and improve patient safety across the region.
Meanwhile, speaking with reporters after the conference, Dr. Juwe D. Kercula, conference organizer, said that the two-day interaction was very fruitful, interactive, stating that the LMHRA is grateful to God for bringing members of regulators together to achieve one goal.
According to him, the LMHRA intends to collaborate with several European countries, applauding them for their past support. “We hope that they will build upon even what they are seeing and listening to, challenges they will have to help with, like the average they help with in the clinical trials,” he added.
